These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33472100)
1. Design of taste-masked swellable drug particles using dry-coating technology with mechanical curing. Saeki I; Kondo K; Furukoshi Y; Watanabe Y; Niwa T Eur J Pharm Biopharm; 2021 Mar; 160():9-22. PubMed ID: 33472100 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drašković M; Medarević D; Aleksić I; Parojčić J Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology. Kondo K; Niwa T; Ozeki Y; Ando M; Danjo K Chem Pharm Bull (Tokyo); 2011; 59(10):1214-20. PubMed ID: 21963629 [TBL] [Abstract][Full Text] [Related]
4. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Cerea M; Zheng W; Young CR; McGinity JW Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801 [TBL] [Abstract][Full Text] [Related]
5. Applying a novel electrostatic dry powder coating technology to pellets. Yang Q; Ma Y; Zhu J Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275 [TBL] [Abstract][Full Text] [Related]
6. Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form. Mizumoto T; Tamura T; Kawai H; Kajiyama A; Itai S Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):530-5. PubMed ID: 18379103 [TBL] [Abstract][Full Text] [Related]
7. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride. Cantor SL; Khan MA; Gupta A Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481 [TBL] [Abstract][Full Text] [Related]
8. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate. Kondo K; Ito N; Niwa T; Danjo K Int J Pharm; 2013 Sep; 453(2):523-32. PubMed ID: 23796831 [TBL] [Abstract][Full Text] [Related]
9. A novel electrostatic dry powder coating process for pharmaceutical dosage forms: immediate release coatings for tablets. Qiao M; Zhang L; Ma Y; Zhu J; Chow K Eur J Pharm Biopharm; 2010 Oct; 76(2):304-10. PubMed ID: 20600889 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate. Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790 [TBL] [Abstract][Full Text] [Related]
11. Building Process Understanding of Fluid Bed Taste Mask Coating of Microspheres. Silva BS; Santangelo M; Colbert MJ; Fauteux-Lefebvre C; Bartlett JA; Lapointe-Garant PP; Gosselin R AAPS PharmSciTech; 2019 Apr; 20(5):173. PubMed ID: 31020426 [TBL] [Abstract][Full Text] [Related]
12. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations. Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of coat uniformity and taste-masking efficiency of irregular-shaped drug particles coated in a modified tangential spray fluidized bed processor. Xu M; Heng PW; Liew CV Expert Opin Drug Deliv; 2015; 12(10):1597-606. PubMed ID: 26051826 [TBL] [Abstract][Full Text] [Related]
14. Is rat a good model for assessment of particulate-based taste-masked formulations? Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218 [TBL] [Abstract][Full Text] [Related]
15. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules. Kawano Y; Ito A; Sasatsu M; Machida Y Yakugaku Zasshi; 2010 Jan; 130(1):81-6. PubMed ID: 20046070 [TBL] [Abstract][Full Text] [Related]
16. Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance. Kondo K; Ando C; Niwa T Int J Pharm; 2019 Jan; 554():387-398. PubMed ID: 30513400 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the film formation of the dry coating process. Kablitz CD; Urbanetz NA Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928 [TBL] [Abstract][Full Text] [Related]
18. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride. Stange U; Führling C; Gieseler H J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules. Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673 [TBL] [Abstract][Full Text] [Related]
20. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating. Kunnath K; Huang Z; Chen L; Zheng K; Davé R Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]